Global Market Study on Home Infusion Therapy: Needless Connectors to Witness Highest Growth by 2020

115
Published Date: 2014-07-31

Home Infusion therapy involves administration of intravenous medication into patient’s body at their homes. It involves the use of needle or catheter for proper medication. It is based on doctor’s prescription. It takes place when oral medication is not effective to cure disease. Home infusion therapy helps in reducing time spent in hospitals, nursing homes and clinics. It includes continuous and slow administration of drug, antibiotic, nutrient and other fluid into vein and tissues on a monthly, weekly and daily basis, depending on the condition of patients and therapy being used in treatment. It is provided by trained professionals and nurses. It is an effective and safe alternative for patients care as it provides friendly environment to inpatients which helps in early recovery of patients. Diseases which are cured through infusion therapy include infections which are unresponsive to oral medication, cancer and cancer-related pain, gastrointestinal diseases and dehydration. It is also used for curing diabetes, health failure, cystic fibrosis, dehydration, transplants, acute infections or nutritional support. It also helps in improving medication adherence and reducing unplanned hospital stay. Infusion pump, intravenous set and needleless connectors are some of the infusion devices which are used for medication.


North America has the largest market for home infusion therapy. This is due to rising number of chronic diseases, increasing healthcare costs in the region. Some of the other large markets for home infusion therapy are Japan, China, Germany and the U.S.


The cost of home infusion therapy is less as compared to hospital stay costs. This is a major reason for increasing demand of home infusion therapy. In addition, other factors such as rising aging population and increasing number of chronic diseases such as diabetes and cancer, technology advancement in infusion devices and increasing application of infusion devices in pain relieving are driving the market for home infusion therapy. As a result, the market is expected to grow at a CAGR of about 9.0% from 2014 – 2020. However, increasing risk with patient’s safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are inhibiting the growth of home infusion therapy market.


Rising acceptance for specialty infusion therapy has opened new opportunity for home infusion therapy market. Increasing number of mergers and acquisitions, increasing uses of ambulatory infusion pump and rising number of product innovations are some of the major trends that have been observed in home infusion therapy market. 


Some of the major companies operating in the home infusion therapy market are Baxter, B. Braun Melsungen AG, Caesarea Medical Electronics, Fresenius Kabi AG, Smiths Medical, CareFusion Corporation, ICU Medical, Inc., JMS Co. Ltd and TERUMO CORPORATION.  


The report segments the market by device: infusion pump, intravenous set and needleless connectors; by application of home infusion therapy: anti-infective/ antibiotics, enteral nutrition, specialty pharmaceuticals, total parental nutrition (TPN), pain management, chemotherapy and hydration infusion pump; by diseases of home infusion therapy: diabetes and cancer; by geographies: North America, Europe, Asia Pacific and Rest of the World (Row). The report provides the market size and forecast for the different segments under these geographies for the period of 2010 to 2020. The report also provides porters five forces analysis of global home infusion therapy market. 

Table of Content


Chapter 1 Preface 9

1.1 Report Description 9

1.2 Research Methodology 10

1.3 Assumptions 10


Chapter 2 Market Synopsis 11


Chapter 3 Porter Five Forces Analysis 13

3.1 Bargaining power of suppliers 13

3.2 Bargaining power of buyers 14

3.3 Threats of new entrants 14

3.4 Threats of substitutes 14

3.5 Intensity of rivalry 14


Chapter 4 Industry Overview 16

4.1 Market Introduction 16

4.2 Market Drivers 17

      4.2.1 Expanding home care market for infusion therapy 17

      4.2.2 Increasing application of infusion devices in pain relieving 18

      4.2.3 Rising aging population and increasing number of chronic diseases 18

      4.2.4 Technology advancement in infusion devices 19

4.3 Impact Analysis of Market Drivers 20

4.4 Market Restraints 20

      4.4.1 Increasing risk for patients safety and occurrence of mistakes while using infusion devices 21

      4.4.2 Issues related to reimbursement policies for home infusion therapy 21

4.5 Impact Analysis of Market Restraints 22

4.6 Opportunities 22

      4.6.1 Rise in acceptance for speciality infusion therapy 22

4.7 Market Trends 23

      4.7.1 Increasing numbers of mergers and acquisitions 23

      4.7.2 Increasing uses of ambulatory infusion pump 23

4.8 Rising number of product innovations 24


Chapter 5 Market Size and Forecast by type of device 26

5.1 Infusion Pumps 28

5.2 Intravenous Sets 29

5.3 Needleless connectors 31


Chapter 6 Market Size and Forecast of Infusion pumps by devices 33

6.1 Volumetric infusion pump 35

6.2 Syringe infusion pump 37

6.3 Insulin Infusion pump 39

6.4 Enteral Infusion pump 40

6.5 Ambulatory Infusion pump 42

6.6 Patient Control Analgesia (PCA) Infusion 44

6.7 Implantable Infusion pump 46


Chapter 7 Market Size and Forecast by Application 48

7.1 Anti- infectives/ antibiotics 51

7.2 Enteral Nutrition 53

7.3 Speciality Pharmaceuticals 55

7.4 Total Parenteral Nutrition (TPN) 56

7.5 Pain Management 58

7.6 Chemotherapy 60

7.7 Hydration infusion pump 62


Chapter 8 Market Size and Forecast by Type of disease 64

8.1 Diabetes 65

8.2 Cancer 67


Chapter 9 Market Size and Forecast by Region 69

9.1 Global 69

9.2 North America 71

9.3 Europe 74

9.4 Asia 78


Chapter 10 Competitive Scenario 81


Chapter 11 Company Profiles 83

      11.1.1 Overview 83

      11.1.2 Products & Services 83

      11.1.3 Financial Performance 85

      11.1.4 Recent Developments 85

11.2 B. Braun Melsungen AG 86

      11.2.1 Overview 86

      11.2.2 Products & Services 86

      11.2.3 Financial Performance 89

      11.2.4 Recent Developments 89

11.3 Caesarea Medical Electronics 90

      11.3.1 Overview 90

      11.3.2 Products & Services 90

      11.3.3 Financial Performance 91

      11.3.4 Recent Developments 91

11.4 Fresenius Kabi AG 92

      11.4.1 Overview 92

      11.4.2 Products & Services 92

      11.4.3 Financial Performance Fresenius Kabi AG 94

      11.4.4 Recent Developments 94

11.5 Smiths Medical 95

      11.5.1 Overview 95

      11.5.2 Products and Services 95

      11.5.3 Financial Performance 97

      11.5.4 Recent Developments 97

11.6 CareFusion Corporation 98

      11.6.1 Overview 98

      11.6.2 Products & Services 98

      11.6.3 Financial Performance 99

      11.6.4 Recent Developments 100

11.7 ICU Medical, Inc. 101

      11.7.1 Overview 101

      11.7.2 Products & Services 102

      11.7.3 Financial Performance 102

      11.7.4 Recent Developments 103

11.8 JMS Co. Ltd. 104

      11.8.1 Overview 104

      11.8.2 Products & Services 104

      11.8.3 Financial Performance 105

      11.8.4 Recent Developments 106

11.9 Baxter 106

      11.9.1 Overview 106

      11.9.2 Products & Services 107

      11.9.3 Financial Performance 108

      11.9.4 Recent Developments 108

11.10 TERUMO CORPORATION 109

      11.10.1 Overview 109

      11.10.2 Products & Services 109

      11.10.3 Financial Performance 110

      11.10.4 Recent Developments 110

Home Infusion therapy involves administration of intravenous medication into patient’s body at their homes. It involves the use of needle or catheter for proper medication. It is based on doctor’s prescription. It takes place when oral medication is not effective to cure disease. Home infusion therapy helps in reducing time spent in hospitals, nursing homes and clinics. It includes continuous and slow administration of drug, antibiotic, nutrient and other fluid into vein and tissues on a monthly, weekly and daily basis, depending on the condition of patients and therapy being used in treatment. It is provided by trained professionals and nurses. The cost of home infusion therapy is less as compared to hospital stay costs, this helps in increasing demand of home infusion therapy. As a result, the market is expected to grow at a CAGR of about 9.0% from 2014 – 2020.


Some of the major drivers which help in increasing demand for home infusion therapy are rising aging population, increasing number of chronic diseases, expansion of home care market for infusion therapy, technological advancement in infusion devices and increasing application of infusion devices in pain relieving. However, increasing risk with patient’s safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are some factors inhibiting the growth of the home infusion therapy market.


North America has the largest market for home infusion therapy followed by Europe. Some of the other fast growing markets for home infusion therapy are Japan, China, Germany and the U.S. Anti-infective/ antibiotics has the largest application based market in the global home infusion market and is expected to grow at a CAGR of about 9.8% from 2014 – 2020. On the basis of types of devices, home infusion therapy market can be segmented into infusion pump, intravenous set and needleless connectors. 


Baxter is one the leading player in the home infusion therapy market. Other major players in home infusion therapy market are B. Braun Melsungen AG, Fresenius Kabi AG, CareFusion Corporation.


global-home-infusion-therapy-market